Yuhan Corporation clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
| First posted | New trial filing | Phase | Status |
|---|---|---|---|
| 2026-11-03 | NCT07912827 Bioequivalence Study Between YHP2508A and YHR2601 in Healthy Subjects | Phase 1 | Recruiting |
| 2026-11-03 | NCT07912840 Bioequivalence Study Between YHP2508B and YHR2602 in Healthy Subjects | Phase 1 | Recruiting |
Active trials by phase
| Phase 1 | 3 | |
| Phase 1/2 | 3 | |
| Phase 2 | 1 | |
| Phase 3 | 1 | |
| Phase 4 | 1 |
Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Lung Cancer (3) · Non-Small Cell Lung Cancer (NSCLC) (3) · Hypertension (2) · Breast Cancer (1) · Cervical Cancer (1) · Esophageal Cancer (1) · Gastric Cancer (1) · Head & Neck Cancer (1) · HER2-Positive Cancer (1)
Get alerts when Yuhan Corporation's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.